These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30220291)

  • 1. Predictability of serum vancomycin concentrations using the kinetic estimated glomerular filtration rate formula for critically ill patients
.
    Harada D; Uchino S; Kawakubo T; Takinami M
    Int J Clin Pharmacol Ther; 2018 Dec; 56(12):612-616. PubMed ID: 30220291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients.
    Aubron C; Corallo CE; Nunn MO; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Oct; 45(10):1193-8. PubMed ID: 21896920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.
    Neuman G; Nulman I; Adeli K; Koren G; Colantonio DA; Helldén A
    J Clin Pharmacol; 2014 Jul; 54(7):785-91. PubMed ID: 24596064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hoek's formula, a cystatin C-based prediction formula for determining the glomerular filtration rate, is the most effective method for original adjusting the dosage of vancomycin.
    Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Yasukawa M; Inoue T; Murase M; Araki H
    Int J Clin Pharmacol Ther; 2007 Nov; 45(11):592-7. PubMed ID: 18077923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influencing factors achieving target vancomycin trough level in critically ill patients].
    Wang JL; Wang HF; Shi MJ; Xu JY; Huang LL; Li Q; Liu SQ; Huang YZ
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):572-576. PubMed ID: 31365978
    [No Abstract]   [Full Text] [Related]  

  • 7. Glomerular filtration rate equations do not accurately predict vancomycin trough concentrations in pediatric patients.
    Alford EL; Chhim RF; Crill CM; Hastings MC; Ault BH; Shelton CM
    Ann Pharmacother; 2014 Jun; 48(6):691-6. PubMed ID: 24646680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.
    Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W
    Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C and/or creatinine-based estimated glomerular filtration rate for prediction of vancomycin clearance in long-stay critically ill patients with persistent inflammation, immunosuppression and catabolism syndrome (PICS): a population pharmacokinetics analysis.
    Huang J; Wang X; Hao C; Yang W; Zhang W; Liu J; Qu H
    Intern Emerg Med; 2021 Oct; 16(7):1883-1893. PubMed ID: 33728578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
    Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
    Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
    Denetclaw TH; Dowling TC; Steinke D
    Ann Pharmacother; 2013 Dec; 47(12):1611-7. PubMed ID: 24259632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic estimated glomerular filtration rate in critically ill patients: beyond the acute kidney injury severity classification system.
    de Oliveira Marques F; Oliveira SA; de Lima E Souza PF; Nojoza WG; da Silva Sena M; Ferreira TM; Costa BG; Libório AB
    Crit Care; 2017 Nov; 21(1):280. PubMed ID: 29149864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].
    Pondel J; Krajewski P; Królikowska N; Tobiasz A; Augustyniak-Bartosik H; Hurkacz M
    Pol Merkur Lekarski; 2017 Apr; 42(250):145-150. PubMed ID: 28530212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of glomerular filtration rate to adjust vancomycin dosage in critically ill patients: superiority of the Chronic Kidney Disease Epidemiology Collaboration equation?
    Conil JM; Georges B; Breden A; Ruiz S; Cougot P; Fourcade O; Saivin S
    Anaesth Intensive Care; 2014 Mar; 42(2):178-84. PubMed ID: 24580382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit.
    Qian X; Du G; Weng C; Zhou H; Zhou X
    Int J Infect Dis; 2017 Jul; 60():17-22. PubMed ID: 28457752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Kinetic Glomerular Filtration Rate in Adults with Stable and Unstable Kidney Function: Vancomycin as the Motivating Example.
    Pai MP; DeBacker KC
    Pharmacotherapy; 2020 Sep; 40(9):872-879. PubMed ID: 32640054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in vancomycin pharmacokinetics in critically ill infants.
    Gous AG; Dance MD; Lipman J; Luyt DK; Mathivha R; Scribante J
    Anaesth Intensive Care; 1995 Dec; 23(6):678-82. PubMed ID: 8669599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin monitoring: one or two serum levels?
    Andrés I; López R; Pou L; Piñol F; Pascual C
    Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of serum cystatin C to determine the dose of vancomycin in critically ill patients.
    Suzuki A; Imanishi Y; Nakano S; Niwa T; Ohmori T; Shirai K; Yoshida S; Furuta N; Takemura M; Ito H; Ieiri I; Seishima M; Ogura S; Itoh Y
    J Pharm Pharmacol; 2010 Jul; 62(7):901-7. PubMed ID: 20636878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
    Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Inoue T; Murase M; Yasukawa M; Araki H
    Ther Drug Monit; 2007 Apr; 29(2):261-4. PubMed ID: 17417082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.